Frequency of temporomandibular dysfunction in patients with rheumatic disease

  • María Eugenia Acosta Universidad Autónoma de Asunción, Facultad de Ciencias de la Salud. Asunción, Paraguay
  • Angela Maidana Universidad Autónoma de Asunción, Facultad de Ciencias de la Salud. Asunción, Paraguay
  • Gabriela Ávila Pedretti Universidad Nacional de Asunción, Facultad de Ciencias Médicas, Hospital de Clínicas, Departamento de Reumatología. San Lorenzo, Paraguay
  • Carmen Portillo Universidad Autónoma de Asunción, Facultad de Ciencias de la Salud. Asunción, Paraguay
  • Paula Carpinelli Universidad Autónoma de Asunción, Facultad de Ciencias de la Salud. Asunción, Paraguay
  • Margarita Duarte Universidad Autónoma de Asunción, Facultad de Ciencias de la Salud. Asunción, Paraguay
Keywords: Temporomandibular disorder, rheumatic diseases, Fonseca Questionnaire

Abstract

Introduction: Temporomandibular disorder (TMD) may difficult some basic human functions, such as feeding or communication. TMD may be due to specific disorders of the temporomandibular joint, the masticatory muscles or both. Objective: To measure the frequency and severity of TMD in rheumatic patients. Methods: Descriptive observational study on a non-probabilistic sample of rheumatic patients conducted between May and June 2016. The Fonseca Questionnaire and Anamnestic Index was used to measure TMD. Results: The survey was conducted in 51 consecutive patients. The mean age was 45 years old (range 30 – 56). Systemic lupus erythematosus (SLE) was the most frequent disease (49 %) followed by rheumatoid arthritis (RA) (35.3 %) and systemic sclerosis (9.8 %). 98 % presented a sign or symptom of TMD. All RA and SS and 98 % of SLE patients presented a sign or symptom of TMD. Conclusion: TTM is a common condition in patients with rheumatic diseases such as RA , SLE and SSc, being of moderate intensity in most patients in our series.

Downloads

Download data is not yet available.

References

(1) Abrao AL, Santana CM, Bezerra AC, Amorim RF, Silva MB, Mota LM, et al. What rheumatologists should know about orofacial manifestations of autoimmune rheumatic diseases. Rev Bras Reumatol. 2016;11(16):00021-8.

(2) Aceves-Avila FJ, Chavez-Lopez M, Chavira-Gonzalez JR, Ramos- R emus C. Temporomandibular joint dysfunction in various rheumatic diseases. Reumatismo. 2013;65(3):126-30. doi: 10.4081/reumatismo.2013.126.

(3) Acosta Ortiz R. Una revisión de la literatura sobre la relación causal entre los factores oclusales (FO) y los desórdenes temporomandibulares (DTM): VI: conclusiones finales. Revista Facultad de OdontologíaUniversidad de Antioquia. 2011;23:126-57.

(4) Machado M, Fasanella M. Ansiedad y disfunción temporomandibular ODOUS Científica. 2009;10(1).

(5) Murrieta J, Pérez L, Allendelagua R, Linares C, Juárez L, et a. Prevalencia de chasquido en la ATM y su relación con el tipo de oclusión dental, en un grupo de jóvenes mexicanos. Revista ADM. 2011;68(5).

(6) Sardiña Valdés M, Casas Acosta J. Anomalías de la oclusión dentaria asociadas a la disfunción temporomandibular. Revista Médica Electrónica. 2010;32:0-.

(7) González EJ, Gutiérrez M, Pellitero B. Manifestaciones clínicas detrastornos temporomandibulares en bruxópatas. Correo Científico Médico de Holguín. 2011;15(4).

(8) Cabo García R, Grau León I, Sosa Rosales M. Frecuencia de trastornos temporomandibulares en el área del Policlínico Rampa, Plaza de la Revolución. Revista Habanera de Ciencias Médicas. 2009;8:0-.

(9) Sidebottom AJ, Salha R. Management of the temporomandibular joint in rheumatoid disorders. British Journal of Oral and Maxillofacial Surgery. 2013;51(3):191-8.

(10) Farronato G, Garagiola U, Carletti V, Cressoni P, Bellintani C. Psoriatic arthritis: temporomandibular joint involvement as the first articular phenomenon. Quintessence Int. 2010;41(5):395-8.

(11) Jonsson R, Lindvall AM, Nyberg G. Temporomandibular joint involvement in systemic lupus erythematosus. Arthritis Rheum. 1983;26(12):1506-10.

(12) Fernandes EG, Savioli C, Siqueira JT, Silva CA. Oral health and the masticatory system in juvenile systemic lupus erythematosus. Lupus. 2007;16(9):713-9.

(13) C rincoli V, Fatone L, Fanelli M, Rotolo R, Chialà A, Favia G, et al. Orofacial Manifestations and Temporomandibular Disorders of Systemic Scleroderma: An Observational Study. International Journal of Molecular Sciences. 2016;17(8):1189.

(14) Lazaro J. Validación del índice anamnésico simplificado de Fonseca para el diagnóstico de trastornos temporomandibulares 2008.

(15) Hiz O, Ediz L, Ozkan Y, Bora A. Clinical and magnetic resonance imaging findings of the temporomandibular joint in patients with rheumatoid arthritis. J Clin Med Res. 2012;4(5):323-31. Epub 2012 Sep 12.

(16) Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569-81.

(17) Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-24.

(18) Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.

(19) Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677-86. doi: 10.1002/art.

(20) Van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum.,2013;65(11): 2737-47.

(21) Dolwick M. Temporomandibular disorders. Koopman WJ, Moreland LW, editors. Philadelphia, PA: Lippincott Williams & Wilkins; 2005.

(22) Aliko A, Ciancaglini R, Alushi A, Tafaj A, Ruci D. Temporomandibular joint involvement in rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis. International Journal of Oral and Maxillofacial Surgery. 2011;40(7):704-9.

(23) Hoyuela CPS, Furtado RNV, Chiari A, Natour J. Oro-facial evaluation of women with rheumatoid arthritis. Journal of Oral Rehabilitation. 2015;42(5):370-7.

(24) Lin YC, Hsu ML, Yang JS, Liang TH, Chou SL, Lin HY. Temporomandibular joint disorders in patients with rheumatoid arthritis. J Chin Med Assoc. 2007;70(12):527-34. doi:,10.1016/S726-4901(08)70055-8.

(25) Carlsson GE. Epidemiology and treatment need for temporomandibular disorders. J Orofac Pain. 1999;13(4):232-7.

(26) Ferreira EL, Christmann RB, Borba EF, Borges CT, Siqueira JT, Bonfa E. Mandibular function is severely impaired in systemic sclerosis patients. J Orofac Pain. 2010;24(2):197-202.

(27) Matarese G, Isola G, Alibrandi A, Lo Gullo A, Bagnato G, Cordasco G , et al. Occlusal and MRI characterizations in systemic sclerosis patients: A prospective study from Southern Italian cohort. Joint Bone Spine. 2016;83(1):57-62.

(28) Fischer DJ, Patton LL. Scleroderma: oral manifestations and treatment challenges. Spec Care Dentist. 2000;20(6):240-4.

(29) García González V, Hernández Yane A, Solis Cartas U. Incidencia de la afección de la articulación temporomandibular en pacientes con enfermedades reumáticas. Revista Cubana de Reumatología. 2014;16:373-8.

Published
2016-06-01
How to Cite
1.
Acosta ME, Maidana A, Ávila Pedretti G, Portillo C, Carpinelli P, Duarte M. Frequency of temporomandibular dysfunction in patients with rheumatic disease. Rev. parag. reumatol. [Internet]. 2016Jun.1 [cited 2025Jun.27];2(1):18-3. Available from: http://www.revista.spr.org.py/index.php/spr/article/view/28
Section
ORIGINAL ARTICLES